tarenflurbil has been researched along with l 685458 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kreft, AF; Martone, R; Porte, A | 1 |
| Baumann, K; Dittrich, M; Greiner, C; Hieke, M; Ness, J; Schubert-Zsilavecz, M; Steri, R; Weggen, S; Werz, O; Zettl, H | 1 |
| Golshayan, D; Juillerat-Jeanneret, L; Kumar, R | 1 |
2 review(s) available for tarenflurbil and l 685458
| Article | Year |
|---|---|
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Drug Discovery; Humans; Models, Biological; Protease Inhibitors | 2009 |
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.
Topics: Amyloid Precursor Protein Secretases; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Carcinogenesis; Clinical Trials as Topic; Fibrosis; Genes, Tumor Suppressor; Humans; Inflammation; Ligands; Neoplasms; Receptors, Notch; Signal Transduction | 2016 |
1 other study(ies) available for tarenflurbil and l 685458
| Article | Year |
|---|---|
Design, synthesis, and biological evaluation of a novel class of gamma-secretase modulators with PPARgamma activity.
Topics: Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Caproates; Chlorocebus aethiops; CHO Cells; COS Cells; Cricetinae; Cricetulus; Cyclooxygenase Inhibitors; Drug Design; Humans; Peptide Fragments; PPAR gamma; Pyrimidines; Receptors, Notch; Sheep; Structure-Activity Relationship; Transcriptional Activation | 2010 |